NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Breast Cancer



Research in the area of breast cancer reported from University of Toronto



June 25th, 2009

In this recent study, researchers in Toronto, Canada conducted a study "To develop a simple method for the quantification of -H2AX focus number, density and size. MDA-MB-468 human breast cancer cells were treated overnight with 111In-diethylenetriaminepentaacetic acid human epidermal growth factor (111In-DTPA-hEGF, 0-142kBq/pmol) or exposed to -radiation to induce DNA double strand breaks (DSB)."

"DNA DSB formation was evaluated by detection of phosphorylated histone H2AX on serine 139 (-H2AX) using immunofluorescence. Confocal microscopy was used to capture images of -H2AX foci and cell nuclei. Image-J software with customized macros was used to quantify -H2AX foci....


Source: Women's Health Weekly (2009-06-25)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login